Patent details

Basic Information

Publication number:

EP2364729

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP101751501

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IL-17 antagonistic antibodies

French Title of Invention:

Anticorps antagonistes IL-17

German Title of Invention:

Antagonistische IL-17-Antikörper

SPC Number:

Dates

Filing date:

04/08/2005

Grant date:

14/05/2014

EP Publication Date:

14/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/09/2011

EP B1 Publication Date:

14/05/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/08/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/08/2005

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Jeschke Margit

Address:

Switzerland (CH)

2

Name:

Di Padova Franco E.

Address:

Switzerland (CH)

3

Name:

Rondeau Jean-Michel

Address:

Switzerland (CH)

4

Name:

Hofstetter Hans

Address:

Switzerland (CH)

5

Name:

Van den Berg Wim

Address:

Netherlands (NL)

6

Name:

Gram Hermann

Address:

Germany (DE)

Priority

Priority Number:

0417487

Priority Date:

05/08/2004

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/07/2024

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages